I 
108TH CONGRESS 
1ST SESSION H. R. 2086
To reauthorize the Office of National Drug Control Policy. 
IN THE HOUSE OF REPRESENTATIVES 
MAY 14, 2003
Mr. SOUDER (for himself and Mr. TOM DAVIS of Virginia) introduced the fol-
lowing bill; which was referred to the Committee on Government Reform, 
and in addition to the Committees on the Judiciary, Energy and Com-
merce, and Select Intelligence (Permanent Select), for a period to be sub-
sequently determined by the Speaker, in each case for consideration of 
such provisions as fall within the jurisdiction of the committee concerned 
A BILL 
To reauthorize the Office of National Drug Control Policy.
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE; REFERENCES; TABLE OF CON-
TENTS. 
(a) SHORT TITLE.—This Act may be cited as the 
‘‘Office of National Drug Control Policy Reauthorization 
Act of 2003’’. 
(b) AMENDMENT OF OFFICE OF NATIONAL DRUG 
CONTROL POLICY REAUTHORIZATION ACT OF 1998.—Ex-
cept as otherwise expressly provided, whenever in this Act
an amendment or repeal is expressed in terms of an 
amendment to, or repeal of, a section or other provision, 
the reference shall be considered to be made to a section 
or other provision of the Office of National Drug Control 
Policy Reauthorization Act of 1998 (Public Law 105–277; 
21 U.S.C. 1701 et seq.). 
(c) TABLE OF CONTENTS.—The table of contents of 
this Act is as follows:
Sec. 1. Short title; references; table of contents. 
Sec. 2. Amendments to definitions. 
Sec. 3. Amendments relating to appointment and duties of Director and Deputy 
Directors. 
Sec. 4. Amendments relating to coordination with other agencies. 
Sec. 5. Development, submission, implementation, and assessment of National 
Drug Control Strategy. 
Sec. 6. High intensity drug trafficking areas program. 
Sec. 7. Funding for certain high intensity drug trafficking areas. 
Sec. 8. Amendments relating to Counter-Drug Technology Assessment Center. 
Sec. 9. Repeals. 
Sec. 10. National Youth Anti-Drug Media Campaign. 
Sec. 11. Authorization of appropriations. 
Sec. 12. Extension of termination date.
SEC. 2. AMENDMENTS TO DEFINITIONS. 
(a) AMENDMENTS TO DEFINITIONS.—Section 702 is 
amended—
(1) in paragraph (1)—
(A) by striking ‘‘and’’ at the end of sub-
paragraph (F); 
(B) by striking the period at the end of 
subparagraph (G); and 
(C) by adding at the end the following: 
‘‘(H) interventions for drug abuse and de-
pendence; and
‘‘(I) international drug control coordina-
tion and cooperation with respect to activities 
described in this paragraph.’’. 
(2) in paragraph (9), by striking ‘‘implicates’’ 
and inserting ‘‘indicates’’; 
(3) in paragraph (10)—
(A) by striking ‘‘and’’ at the end of sub-
paragraph (B); 
(B) by striking the period at the end of 
subparagraph (C) and inserting ‘‘; and’’; and 
(C) by adding at the end the following: 
‘‘(D) domestic drug law enforcement, in-
cluding law enforcement directed at drug 
users.’’; and 
(4) in paragraph (11)—
(A) by inserting before the semicolon in 
subparagraph (A) the following: ‘‘(including 
source country programs, and law enforcement 
outside the United States)’’; 
(B) by inserting ‘‘and’’ after the semicolon 
in subparagraph (B); 
(C) by striking ‘‘; and’’ at the end of sub-
paragraph (C) and inserting a period; and 
(D) by striking subparagraph (D).
(b) CONFORMING AMENDMENTS.—Section 703(b)(3) 
is amended—
(1) in subparagraph (A), by striking ‘‘(G)’’ and 
inserting ‘‘(H)’’; and 
(2) in subparagraph (C)—
(A) by striking ‘‘(C)’’ and inserting ‘‘(D)’’; 
and 
(B) by striking ‘‘and subparagraph (D) of 
section 702(11)’’. 
SEC. 3. AMENDMENTS RELATING TO APPOINTMENT AND 
DUTIES OF DIRECTOR AND DEPUTY DIREC-
TORS. 
(a) DESIGNATION
OF OTHER OFFICERS.—Section 
704(a)(3) is amended—
(1) by striking ‘‘permanent employee’’ and in-
serting ‘‘officer or employee’’; and 
(2) by striking ‘‘serve as the Director’’ and in-
serting ‘‘serve as the acting Director’’. 
(b) 
RESPONSIBILITIES
OF
DIRECTOR.—Section 
704(b) is amended—
(1) in paragraph (4), by striking ‘‘Federal de-
partments and agencies engaged in drug enforce-
ment,’’ and inserting ‘‘National Drug Control Pro-
gram agencies,’’;
(2) by inserting ‘‘and’’ at the end of paragraph 
(12); 
(3) by striking paragraphs (13) and (14); and 
(4) by redesignating paragraph (15) as para-
graph (13). 
(c) REVIEW
AND CERTIFICATION
OF NATIONAL 
DRUG CONTROL PROGRAM BUDGET.—Section 704(c)(3) 
is amended—
(1) by redesignating subparagraphs (C) and 
(D) as subparagraphs (D) and (E), respectively; 
(2) by inserting after subparagraph (B) the fol-
lowing new subparagraph: 
‘‘(C) SPECIFIC REQUESTS.—The Director 
shall not confirm the adequacy of any budget 
request that—
‘‘(i) requests funding for Federal law 
enforcement activities that do not ade-
quately compensate for transfers of drug 
enforcement resources and personnel to 
law enforcement and investigation activi-
ties not related to drug enforcement as de-
termined by the Director;
‘‘(ii) requests funding for law enforce-
ment activities on the borders of the 
United States that do not adequately di-
rect resources to drug interdiction and en-
forcement as determined by the Director; 
‘‘(iii) requests funding for drug treat-
ment activities that do not provide ade-
quate result and accountability measures 
as determined by the Director; 
‘‘(iv) requests funding for any activi-
ties of the Safe and Drug Free Schools 
Program that do not include a clear anti-
drug message; or 
‘‘(v) requests funding to enforce sec-
tion 484(r)(1) of the Higher Education 
Act of 1965 (20 U.S.C. 1091(r)(1)) with 
respect to convictions for drug-related of-
fenses not occurring during a period of en-
rollment for which the student was receiv-
ing any Federal grant, loan, or work as-
sistance.’’; 
(3) in subparagraph (D), as so redesignated, by 
inserting ‘‘and the authorizing Committees for the 
Office’’ after ‘‘House of Representatives’’; and 
(4) in subparagraph (E)(ii)(bb), as so redesig-
nated, by inserting ‘‘and the authorizing Committees 
for the Office’’ after ‘‘House of Representatives’’.
(d) REPROGRAMMING AND TRANSFER REQUESTS.—
Section 
794(c)(4)(A) 
is 
amended 
by 
striking 
‘‘$5,000,000’’ and inserting ‘‘$1,000,000’’. 
(e) POWERS
OF
DIRECTOR.—Section 704(d) is 
amended—
(1) in paragraph (8)(D), by striking ‘‘have been 
authorized by Congress;’’ and inserting ‘‘authorized 
by law;’’; 
(2) in paragraph (9)—
(A) by inserting ‘‘notwithstanding any 
other provision of law,’’ after ‘‘(9)’’; and 
(B) by striking ‘‘Strategy; and’’ and insert-
ing ‘‘Strategy and notify the authorizing com-
mittees of the Congress for the Office of any 
fund control notice issued;’’
(3) in paragraph (10), by striking ‘‘(22 U.S.C. 
2291j).’’ and inserting ‘‘(22 U.S.C. 2291j) and sec-
tion 706 of the Department of State Authorization 
Act for Fiscal Year 2003 (22 U.S.C. 229j–l);’’; 
(4) by adding at the end the following new 
paragraphs: 
‘‘(11) not later than August 1 of each year, 
submit to the President a report, and transmit cop-
ies of the report to the Secretary of State and the
authorizing committees of the Congress for the Of-
fice, that—
‘‘(A) provides the Director’s assessment of 
which countries are major drug transit coun-
tries or major illicit drug producing countries as 
defined in section 481(e) of the Foreign Assist-
ance Act of 1961; 
‘‘(B) provides the Director’s assessment of 
whether each country identified under subpara-
graph (A) has cooperated fully with the United 
States or has taken adequate steps on its own 
to achieve full compliance with the goals and 
objectives established by the United Nations 
Convention Against Illicit Traffic in Narcotic 
Drugs and Psychotropic Substances and other-
wise has assisted in reducing the supply of il-
licit drugs to the United States; and 
‘‘(C) provides the Director’s assessment of 
whether application of procedures set forth in 
section 490(a) through (h) of the Foreign As-
sistance Act of 1961, as provided in section 706 
of the Department of State Authorization Act 
for Fiscal Year 2003, is warranted with respect 
to countries the Director assesses have not co-
operated fully; and
‘‘(12) appoint a United States Interdiction Co-
ordinator under subsection (i).’’.
(f) UNITED STATES INTERDICTION COORDINATOR.—
Section 704 (21 U.S.C. 1703) is further amended by add-
ing at the end the following: 
‘‘(i) 
UNITED
STATES
INTERDICTION
COORDI-
NATOR.—
‘‘(1) IN GENERAL.—There shall be in the Office 
a United States Interdiction Coordinator, who shall 
be appointed by the Director and shall perform du-
ties determined by the Director with respect to co-
ordination of efforts to interdict illicit drugs from 
the United States. 
‘‘(2) APPOINTMENT.—
‘‘(A) IN GENERAL.—Notwithstanding any 
other provision of law (except subparagraph 
(B)), the Director may appoint any individual 
to serve as the United States Interdiction Coor-
dinator. 
‘‘(B) LIMITATION.—The Director may not 
appoint to such position any individual who 
concurrently serves as the head of any other 
Federal department or agency or any subdivi-
sion thereof with responsibility for narcotics 
interdiction activities, except the counter-
narcotics officer of the Department of Home-
land Security appointed under section 878 of 
the Homeland Security Act of 2002 (6 U.S.C. 
458).’’. 
SEC. 4. AMENDMENTS RELATING TO COORDINATION WITH 
OTHER AGENCIES. 
Section 705 is amended—
(1) 
in 
subsection 
(a)(1)(A), 
by 
striking 
‘‘abuse’’; 
(2) by amending paragraph (3) of subsection 
(a) to read as follows: 
‘‘(3) REQUIRED REPORTS.—
‘‘(A) The Secretaries of Agriculture and 
Interior shall, by July 1 of each year, jointly 
submit to the Director and the authorizing 
Committees for the Office an assessment of the 
quantity of illegal drug cultivation and manu-
facturing in the United States on lands owned 
or under the jurisdiction of the Federal Govern-
ment for the preceding year. 
‘‘(B) The Attorney General shall, by July 
1 of each year, submit to the Director and the
authorizing Committees for the Office informa-
tion for the preceding year regarding the num-
ber and type of—
‘‘(i) arrests for drug violations; 
‘‘(ii) prosecutions for drug violations 
by United States Attorneys; and 
‘‘(iii) the number and type of seizures 
of drugs by each component of the Depart-
ment seizing drugs, as well as statistical 
information on the geographic areas of 
such seizures. 
‘‘(C) The Secretary of Homeland Security 
shall, by July 1 of each year, submit to the Di-
rector and the authorizing Committees for the 
Office information for the preceding year re-
garding—
‘‘(i) the number and type of seizures 
of drugs by each component of the Depart-
ment seizing drugs, as well as statistical 
information on the geographic areas of 
such seizures; and 
‘‘(ii) the number of air and maritime 
patrol hours undertaken by each compo-
nent of the Department primarily dedi-
cated to drug supply reduction missions. 
‘‘(D) The Secretary of Defense shall, by 
July 1 of each year, submit to the Director and 
the authorizing Committees for the Office infor-
mation for the preceding year regarding the 
number of air and maritime patrol hours pri-
marily dedicated to drug supply reduction mis-
sions undertaken by each component of the De-
partment of Defense.’’; and 
(3) in subsection (b)(2)(B), by striking ‘‘Pro-
gram.’’ and inserting ‘‘Strategy.’’
SEC. 5. DEVELOPMENT, SUBMISSION, IMPLEMENTATION, 
AND ASSESSMENT OF NATIONAL DRUG CON-
TROL STRATEGY. 
Section 706 is amended to read as follows: 
‘‘SEC. 706. DEVELOPMENT, SUBMISSION, IMPLEMENTATION, 
AND ASSESSMENT OF NATIONAL DRUG CON-
TROL STRATEGY. 
‘‘(a) TIMING, CONTENTS, AND PROCESS FOR DEVEL-
OPMENT AND SUBMISSION OF NATIONAL DRUG CONTROL 
STRATEGY.—
‘‘(1) IN GENERAL.—Not later than February 1 
of each year, the President shall submit to Congress 
a National Drug Control Strategy, which shall set 
forth a comprehensive plan for reducing illicit drug 
use and the consequences of illicit drug use in the 
United States by reducing the demand for illegal 
drugs, limiting the availability of illegal drugs, and
conducting law enforcement activities with respect to 
illegal drugs. 
‘‘(2) CONTENTS.— 
‘‘(A) IN
GENERAL.—The National Drug 
Control Strategy submitted under paragraph 
(1) shall include—
‘‘(i) comprehensive, research-based, 
long-range, quantifiable, goals for reducing 
illicit drug use and the consequences of il-
licit drug use in the United States; 
‘‘(ii) annual objectives and strategy 
for demand reduction, supply reduction, 
and law enforcement activities, specific tar-
gets to accomplish long-range quantifiable 
reduction in illicit drug use as determined 
by the Director, and specific measurements 
to evaluate progress toward the targets 
and strategic goals; 
‘‘(iii) a strategy to reduce the avail-
ability and purity of illegal drugs and the 
level of drug-related crime in the United 
States; 
‘‘(iv) an assessment of Federal effec-
tiveness in achieving the National Drug
Control Strategy for the previous year, in-
cluding—
‘‘(I) a specific evaluation of 
whether the objectives and targets for 
reducing illicit drug use for the pre-
vious year were met and reasons for 
the success or failure of the previous 
year’s Strategy; and 
‘‘(II) an assessment of the avail-
ability and purity of illegal drugs and 
the level of drug-related crime in the 
United States; 
‘‘(v) notification of any program or 
budget priorities that the Director expects 
to significantly change from the current 
Strategy over the next five years; 
‘‘(vi) a review of international, State, 
local, and private sector drug control ac-
tivities to ensure that the United States 
pursues well-coordinated and effective drug 
control at all levels of government; 
‘‘(vii) such statistical data and infor-
mation as the Director deems appropriate 
to demonstrate and assess trends relating 
to illicit drug use, the effects and con-
sequences thereof, supply reduction, de-
mand reduction, drug-related law enforce-
ment, and the implementation of the Na-
tional Drug Control Strategy; and 
‘‘(viii) a supplement reviewing the ac-
tivities of each individual National Drug 
Control Program agency during the pre-
vious year with respect to the National 
Drug Control Strategy and the Director’s 
assessment of the progress of each Na-
tional Drug Control Program agency in 
meeting its responsibilities under the Na-
tional Drug Control Strategy. 
‘‘(B) 
CLASSIFIED
INFORMATION.—Any 
contents of the National Drug Control Strategy 
that involve information properly classified 
under criteria established by an Executive order 
shall be presented to Congress separately from 
the rest of the National Drug Control Strategy. 
‘‘(C) SELECTION OF DATA AND INFORMA-
TION.—In selecting data and information for 
inclusion under subparagraph (A), the Director 
shall ensure—
‘‘(i) the inclusion of data and informa-
tion that will permit analysis of current
trends against previously compiled data 
and information where the Director be-
lieves such analysis enhances long-term as-
sessment of the National Drug Control 
Strategy; and 
‘‘(ii) the inclusion of data and infor-
mation to permit a standardized and uni-
form assessment of the effectiveness of 
drug treatment programs in the United 
States. 
‘‘(3) PROCESS FOR DEVELOPMENT AND SUB-
MISSION.—
‘‘(A) CONSULTATION.—In developing and 
effectively implementing the National Drug 
Control Strategy, the Director—
‘‘(i) shall consult with—
‘‘(I) the heads of the National 
Drug Control Program agencies; 
‘‘(II) Congress; 
‘‘(III) State and local officials; 
‘‘(IV) private citizens and organi-
zations with experience and expertise 
in demand reduction;
‘‘(V) private citizens and organi-
zations with experience and expertise 
in supply reduction; 
‘‘(VI) private citizens and organi-
zations with experience and expertise 
in law enforcement; and 
‘‘(VII) appropriate representa-
tives of foreign governments; 
‘‘(ii) with the concurrence of the At-
torney General, may require the El Paso 
Intelligence Center to undertake specific 
tasks or projects to implement the Na-
tional Drug Control Strategy; 
‘‘(iii) with the concurrence of the Di-
rector of Central Intelligence and the At-
torney General, may request that the Na-
tional Drug Intelligence Center undertake 
specific tasks or projects to implement the 
National Drug Control Strategy; and 
‘‘(iv) may make recommendations to 
the Secretary of Health and Human Serv-
ices on research that supports or advances 
the National Drug Control Strategy. 
‘‘(B) RECOMMENDATIONS.—Recommenda-
tions under subparagraph (A)(iv) may include
recommendations of research to be performed 
at the National Institutes of Health, including 
the National Institute on Drug Abuse, or any 
other appropriate agency within the Depart-
ment of Health and Human Services. 
‘‘(C) INCLUSION IN STRATEGY.—The Na-
tional Drug Control Strategy under this sub-
section shall include a list of each entity con-
sulted under subparagraph (A)(i). 
‘‘(4) SUBMISSION OF REVISED STRATEGY.—The 
President may submit to Congress a revised Na-
tional Drug Control Strategy that meets the require-
ments of this section—
‘‘(A) at any time, upon a determination by 
the President, in consultation with the Director, 
that the National Drug Control Strategy in ef-
fect is not sufficiently effective; or 
‘‘(B) if a new President or Director takes 
office. 
‘‘(b) PERFORMANCE MEASUREMENT SYSTEM.—Not 
later than February 1 of each year, the Director shall sub-
mit to Congress a description of the national drug control 
performance measurement system, designed in consulta-
tion with affected National Drug Control Program agen-
cies, that includes performance measures for the National
Drug Control Strategy and activities of National Drug 
Control Program agencies related to the National Drug 
Control Strategy.’’. 
SEC. 6. HIGH INTENSITY DRUG TRAFFICKING AREAS PRO-
GRAM. 
Section 707 is amended to read as follows: 
‘‘SEC. 707. HIGH INTENSITY DRUG TRAFFICKING AREAS 
PROGRAM. 
‘‘(a) ESTABLISHMENT.—There is established in the 
Office a program to be known as the High Intensity Drug 
Trafficking Areas Program (in this section referred to as 
the ‘‘Program’’). 
‘‘(b) DESIGNATION.—The Director, upon consulta-
tion with the Attorney General, the Secretary of the 
Treasury, the Secretary of Homeland Security, heads of 
the National Drug Control Program agencies, and the 
Governor of each applicable State, may designate any 
specified area of the United States as a high intensity 
drug trafficking area. 
‘‘(c) FACTORS FOR CONSIDERATION.—(1) In consid-
ering whether to designate an area under this section as 
a high intensity drug trafficking area, the Director shall 
consider, in addition to such other criteria as the Director 
considers to be appropriate, the extent to which—
‘‘(A) the area is a major center of illegal drug 
production, manufacturing, importation, or distribu-
tion for the United States and as compared to other 
areas of the United States; 
‘‘(B) State and local law enforcement agencies 
have committed resources to respond to the drug 
trafficking problem in the area, thereby indicating a 
determination to respond aggressively to the prob-
lem; 
‘‘(C) drug-related production, manufacturing, 
importation, or distribution in the area is having a 
significant harmful impact in other areas of the 
United States; and 
‘‘(D) a significant increase in allocation of Fed-
eral resources is necessary to respond adequately to 
drug-related activities in the area. 
‘‘(2) For purposes of paragraph (1)(A), in consid-
ering whether an area is a major center of illegal drug 
production, manufacturing, importation, or distribution as 
compared to other areas of the United States, the Director 
shall consider—
‘‘(A) the quantity of illicit drug traffic entering 
or transiting the area originating in foreign coun-
tries;
‘‘(B) the quantity of illicit drugs produced in 
the area; 
‘‘(C) the number of Federal, State, and local 
arrests, prosecutions, and convictions for drug traf-
ficking and distribution offenses in the area; 
‘‘(D) the degree to which the area is a center 
for the activities of national drug trafficking organi-
zations; and 
‘‘(E) such other criteria as the Director con-
siders appropriate. 
‘‘(d) SOUTHWEST BORDER.—The Director may not 
designate any county contiguous to the international land 
border with Mexico as part of any high intensity drug traf-
ficking area other than a single Southwest Border high 
intensity drug trafficking area. 
‘‘(e) REMOVAL FROM DESIGNATION.—The Director 
may remove an area or portion of an area from designa-
tion as a high intensity drug trafficking area under this 
section upon determination that the area or portion of an 
area no longer is a high intensity drug trafficking area, 
considering the factors in subsections (c) and (d) in addi-
tion to such other criteria as the Director considers to be 
appropriate. 
‘‘(f) REVIEW OF CURRENT AREAS.—Within one year 
from the date of enactment, the Director shall review each
current high intensity drug trafficking area to determine 
whether it continues to warrant designation as a high in-
tensity drug trafficking area, considering the factors in 
subsection (c) in addition to such other criteria as the Di-
rector considers to be appropriate. The Director shall re-
move from designation any high intensity drug trafficking 
area or portion of any high intensity drug trafficking area 
determined to no longer warrant designation. 
‘‘(g) AUTHORITY OF THE DIRECTOR.—After making 
such a designation and in order to provide Federal assist-
ance to the area so designated, the Director may—
‘‘(1) obligate such sums as appropriated for the 
Program, in accordance with subsection (h); 
‘‘(2) direct the temporary reassignment of Fed-
eral personnel to such area, subject to the approval 
of the head of the department or agency that em-
ploys such personnel; and 
‘‘(3) take any other action authorized under 
section 704 to provide increased Federal assistance 
to those areas. 
‘‘(h) ALLOCATION OF FUNDING.—In obligating sums 
appropriated for the Program—
‘‘(1) The Director shall expend no less than 30 
percent of the amounts appropriated under this sec-
tion in the seven high intensity drug trafficking
the public to provide information about illegal 
drug-related activities.’’. 
SEC. 8. AMENDMENTS RELATING TO COUNTER-DRUG TECH-
NOLOGY ASSESSMENT CENTER. 
(a) CHIEF SCIENTIST.—Section 708(b) is amended—
(1) in the heading by striking ‘‘DIRECTOR OF 
TECHNOLOGY.—’’ 
and 
inserting 
‘‘CHIEF
SCI-
ENTIST.—’’; and 
(2) by striking ‘‘Director of Technology,’’ and 
inserting ‘‘Chief Scientist,’’. 
(b) ADDITIONAL RESPONSIBILITIES OF DIRECTOR.—
Section 708(c) is amended to read as follows: 
‘‘(c) ADDITIONAL RESPONSIBILITIES OF THE DIREC-
TOR OF NATIONAL DRUG CONTROL POLICY.—
‘‘(1) 
IN
GENERAL.—The 
Director, 
acting 
through the Chief Scientist shall—
‘‘(A) identify and define the short-, me-
dium-, and long-term scientific and techno-
logical needs of Federal, State, and local law 
enforcement agencies relating to drug enforce-
ment, including—
‘‘(i) advanced surveillance, tracking, 
and radar imaging; 
‘‘(ii) electronic support measures; 
‘‘(iii) communications;